Variant report
Variant | nsv969968 |
---|---|
Chromosome Location | chr5:98640348-98642682 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr5:98641996..98644469-chr5:98647051..98649595,2 | K562 | blood: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs138101632 | chr5:98640821-98640822 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs548256294 | chr5:98640829-98640830 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs142679884 | chr5:98640834-98640835 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs569146637 | chr5:98640866-98640867 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs528346041 | chr5:98640904-98640905 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs188877701 | chr5:98640910-98640911 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs576567277 | chr5:98640938-98640939 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs193235290 | chr5:98640942-98640943 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs184574109 | chr5:98640943-98640944 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs550625570 | chr5:98640962-98640963 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs568828980 | chr5:98640984-98640985 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs536257335 | chr5:98640988-98640989 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs554222558 | chr5:98640998-98640999 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs573528711 | chr5:98641013-98641014 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs534214800 | chr5:98641034-98641035 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs558762735 | chr5:98641035-98641036 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs577002574 | chr5:98641049-98641050 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs188238707 | chr5:98641061-98641062 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs540789465 | chr5:98641081-98641082 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs150499215 | chr5:98641146-98641147 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs563015869 | chr5:98641177-98641178 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs574799852 | chr5:98641241-98641242 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs139465628 | chr5:98641267-98641268 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs542209210 | chr5:98641312-98641313 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs560280983 | chr5:98641332-98641333 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs191094858 | chr5:98641333-98641334 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs149679324 | chr5:98641366-98641367 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs565101632 | chr5:98641386-98641387 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs532367858 | chr5:98641390-98641391 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs7729230 | chr5:98641445-98641446 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
31 | rs545156909 | chr5:98641487-98641488 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs144492417 | chr5:98641551-98641552 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs116061376 | chr5:98641581-98641582 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs548212359 | chr5:98641587-98641588 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs571775804 | chr5:98641590-98641591 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs184019173 | chr5:98641600-98641601 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs139598174 | chr5:98641610-98641611 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs556383439 | chr5:98641611-98641612 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs145522056 | chr5:98641652-98641653 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs577089275 | chr5:98641659-98641660 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs542119177 | chr5:98641690-98641691 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs34065396 | chr5:98641741-98641742 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs538443742 | chr5:98641745-98641746 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs7733881 | chr5:98641755-98641756 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
45 | rs574922088 | chr5:98641803-98641804 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs530932412 | chr5:98641804-98641805 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs541948663 | chr5:98641848-98641849 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs552633458 | chr5:98641859-98641860 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs374798561 | chr5:98641886-98641887 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs147722877 | chr5:98641913-98641914 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 20164919 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Cancer | 16751803 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 17603634 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Melanoma | 18172304 | CNVD |
Glioma | 20126413 | CNVD |
Breast cancer | 17393978 | CNVD |
Cancer | 21359685 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
adenomatous polyposis | 22470819 | CNVD |
Cancer | 22429812 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Liposarcoma | 21253554 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Breast cancer | 21858162 | CNVD |
Leukemia | 17361228 | CNVD |
Myelodysplastic syndrome | 18508791 | CNVD |
5q-syndrome | 17576883 | CNVD |
Gastric cancer | 17908304 | CNVD |
Lung cancer | 16740712 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Barrett''s syndrome | 19417022 | CNVD |
Lung cancer | 18438408 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Bipolar disorder | 18458673 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Breast cancer | 21785460 | CNVD |
Merkel cell carcinoma | 19020549 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 17133270 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Testicular cancer | 18059402 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Prostate cancer | 16573809 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Cancer | 20164920 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
abnormal development | 18461090 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Colorectal cancer | 16774939 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Prostate cancer | 16461572 | CNVD |
Neurocytoma | 17123091 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr5:98640800-98641200 | Enhancers | Fetal Brain Female | brain |
2 | chr5:98641000-98641600 | Enhancers | Monocytes-CD14+_RO01746 | blood |
3 | chr5:98641000-98641800 | Enhancers | Primary monocytes fromperipheralblood | blood |
4 | chr5:98641200-98641600 | Enhancers | Fetal Lung | lung |
5 | chr5:98641600-98643400 | Weak transcription | Monocytes-CD14+_RO01746 | blood |
6 | chr5:98641600-98644800 | Weak transcription | Fetal Lung | lung |
7 | chr5:98641800-98643200 | Weak transcription | Primary monocytes fromperipheralblood | blood |